Efficacy and Safety of Vagus Nerve Stimulation in Lennox–Gastaut Syndrome: A Scoping Review
Open Access
Abstract
Lennox–Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy characterized by drug-resistant seizures, cognitive impairments, and abnormal electroencephalographic patterns. Vagus nerve stimulation (VNS) is a widely used neuromodulation therapy for LGS, but its effects on seizure outcomes, different seizure types, non-seizure outcomes, and adverse events in this population have not been comprehensively reviewed. To conduct a scoping review on the use of VNS in LGS, a literature search was performed in PubMed, OVID, Web of Science, and Embase from inception to 9 June 2024, using relevant keywords and without restrictions on study design. The search yielded forty eligible studies (twenty-four retrospective cohorts, fourteen prospective cohorts, and two registry analyses) comprising 1400 LGS patients treated with VNS. No randomized controlled trials were identified. Across studies, the median seizure reduction ranged from 20.6% to 65%, with 0% to 100% of patients achieving a ≥50% seizure reduction. No consistent preoperative biomarker of VNS responsiveness was identified in LGS. Although inconsistent among different studies, tonic, atonic, and tonic–clonic seizures responded best, while focal seizures responded worst. Improvements in seizure severity, alertness, and quality of life were reported in some studies, but cognitive and adaptive functioning generally remained unchanged. Adverse events were mostly mild and transient, including hoarseness, cough, and paresthesia. Device-related complications and infections were uncommon. In conclusion, further research is needed to better understand VNS’s position in the evolving LGS treatment landscape and its cost effectiveness.Keywords
This publication has 75 references indexed in Scilit:
- Add‐On Deep Brain Stimulation versus Continued Vagus Nerve Stimulation for Childhood Epilepsy (ADVANCE): A Partially Randomized Patient Preference TrialAnnals of Neurology, 2024
- A survey of preferences and expectations for surgical interventions targeting atonic seizures in Lennox-Gastaut syndromeChild's Nervous System, 2024
- Norwegian population‐based study of effectiveness of vagus nerve stimulation in patients with developmental and epileptic encephalopathiesEpilepsia Open, 2024
- Does response to vagus nerve stimulation for drug‐resistant epilepsy differ in patients with and without Lennox–Gastaut syndrome?Brain and Behavior, 2023
- Sleep and respiratory abnormalities in adults with developmental and epileptic encephalopathies using polysomnography and video‐EEG monitoringEpilepsia Open, 2023
- One‐year cost‐effectiveness of callosotomy vs vagus nerve stimulation for drug‐resistant seizures in Lennox‐Gastaut Syndrome: A decision analytic modelEpilepsia Open, 2021
- DBS of Thalamic Centromedian Nucleus for Lennox–Gastaut Syndrome (ESTEL Trial)Annals of Neurology, 2021
- Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndromeActa Neurochirurgica, 2016
- Vagus nerve stimulation: effectiveness and tolerability in patients with epileptic encephalopathiesChild's Nervous System, 2010
- Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick ChildrenChild's Nervous System, 2006